Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (7): 808-813.doi: 10.12092/j.issn.1009-2501.2022.07.012

Previous Articles     Next Articles

Clinical application and research progress of inhaled methoxyflurane

DAI Jingyi, WANG Jingjing, ZHANG Jing, YU Jicheng, LI Nanyang, HUANG Zhiwei   

  1. Laboratory of Phase I Clinical Research, Huashan Hospital, Fudan University, Shanghai 200040, China
  • Received:2022-05-12 Revised:2022-07-18 Online:2022-07-26 Published:2022-08-11

Abstract: As a fluorinated hydrocarbon anesthetic, methoxyflurane may cause serious adverse reactions such as renal damage under anesthetic doses, but its analgesic effect at sub-anaesthetic doses is safe, high tolerability, and short-term acute Good choice for analgesia. This article describes the pharmacokinetics, clinical validity, adverse reactions and clinical application of methoxyflurane, and explores the feasibility of methoxyflurane as an analgesic in clinical application. Methoxyflurane is convenient to use as an inhaled analgesic. It can provide patients with emergency analgesia without intravenous administration. It is a good choice for emergency analgesia in pre-hospital and emergency settings.

Key words: methoxyflurane, inhaled analgesics, pharmacokinetics

CLC Number: